People · Operator
Named in public records as an officer, director or promoter · active 2007–2023 · Pharmaceuticals, Biotechnology, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aeovian Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $125.0M | $297.5M | 2019 |
| Decibel Therapeutics, Inc. | — | Biotechnology | Series C | $87.1M | $2.0B | 2015 |
| Alios Biopharma Inc | — | Pharmaceuticals | Series C | $82.3M | $1.4B | 2014 |
| AnchorTherapeutics, Inc | — | Other | Series B | $24.0M | $83.1M | 2007 |
| Thrasos Innovation Inc. | — | Biotechnology | Series A | $14.0M | $506.1M | 2015 |
| Samsara Therapeutics Inc. | — | Biotechnology | Series A | $10.3M | $230.1M | 2021 |
| Gladius Pharmaceuticals Corp | — | Biotechnology | Seed | $3.8M | $134.2M | 2018 |
| Boswell, Inc. | — | Other Health Care | Pre-Seed | $190K | $1.5M | 2023 |
Jens Eckstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jens Eckstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel Hetu | 2 | 3 |
| Michael Powell | 1 | 14 |
| Jack Nielsen | 1 | 13 |
| Campbell Murray | 1 | 9 |
| John Donovan | 1 | 8 |
| Peter Hirth | 1 | 7 |
| Richard Gaster | 1 | 7 |
| Michael Solomon | 1 | 7 |
| Ben Zadik | 1 | 6 |
| Jean George | 1 | 6 |
| Michael Webb | 1 | 6 |
| Joseph Zakrzewski | 1 | 6 |
| David Lowe | 1 | 5 |
| Kevin Starr | 1 | 5 |
| Peter A. Thompson | 1 | 5 |
| Christopher K. Mirabelli | 1 | 4 |
| Neil A. Exter | 1 | 3 |
| Lawrence Blatt | 1 | 3 |
| IYA KHALIL | 1 | 3 |
| LAUREN SILVERMAN | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.